100 Participants Needed

Peer Navigator Program for Disabilities

(OP-ENS - CL Trial)

SM
Overseen BySusan Magasi, PhD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Susan Magasi
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

The goal of this clinical trial is to learn if a remote peer navigator intervention (OP-ENS - CL) for people with newly acquired physical disabilities returning to community living after rehabilitation improves self-reported social support, health, and community participation. The main questions it aims to answer are:

Do people with acquired physical disabilities who receive the remote peer navigator intervention experience greater social support and self-efficacy than people in the control group?

Do people with acquired physical disabilities who receive the remote peer navigator intervention have better self-reported health and social participation outcomes than people in the control group?

Is the OP-ENS - CL intervention acceptable to people with newly acquired physical disabilities returning to community living?

Do I need to stop taking my current medications for this trial?

The trial information does not specify whether you need to stop taking your current medications. It seems focused on a peer navigator program rather than medication changes.

Is the Peer Navigator Program for Disabilities safe for participants?

The available research does not provide specific safety data for the Peer Navigator Program for Disabilities or its related programs like OP-ENS - CL. The studies focus on adverse events in community care and drug safety, but do not directly address the safety of this specific program.12345

How is the OP-ENS - CL treatment different from other treatments for disabilities?

The OP-ENS - CL treatment is unique because it uses peer navigators, who are individuals with disabilities themselves, to provide structured support and help others with disabilities overcome barriers to healthcare access. This community-based approach focuses on empowerment and personalized action planning, which is not typically found in standard treatments for disabilities.678910

What data supports the effectiveness of the treatment Our Peers - Empowerment and Navigational Support - Community Living (OP-ENS - CL)?

The OP-ENS program, which uses peer health navigators to help people with disabilities access healthcare, is based on evidence showing that similar peer navigator programs have successfully helped underserved communities overcome barriers to healthcare. Additionally, a study on disability care coordination organizations showed significant improvements in healthcare access and quality for people with disabilities, suggesting that structured support can be effective.6791112

Who Is on the Research Team?

SM

Susan Magasi, PhD

Principal Investigator

University of Illinois Chicago

Are You a Good Fit for This Trial?

This trial is for adults who have recently acquired physical disabilities and are transitioning back to community living after rehabilitation. Participants should be willing to engage with a remote peer navigator program.

Inclusion Criteria

Onset of disability within the last 6 months
Transitioned to community living in the past 4 months
Able to speak, read and understand English
See 3 more

Exclusion Criteria

Cognitive, sensory, or physical functional limitations that interfere with effective use of the OP-ENS - CL app.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive a remote peer navigator intervention for 12 months, meeting at least monthly with a peer navigator to address healthcare needs and concerns.

12 months
At least 12 visits (remote)

Follow-up

Participants are monitored for social support, health, and community participation outcomes after the intervention.

1 month
1 visit (remote)

What Are the Treatments Tested in This Trial?

Interventions

  • Our Peers - Empowerment and Navigational Support - Community Living (OP-ENS - CL)
Trial Overview The study tests if the OP-ENS - CL intervention, which involves guidance from peers also living with disabilities, can improve social support, health outcomes, and community participation for these individuals.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Active Control
Group I: OP-ENS - CL InterventionExperimental Treatment1 Intervention
Group II: Usual CareActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Susan Magasi

Lead Sponsor

Northwestern University Feinberg School of Medicine

Collaborator

Trials
42
Recruited
15,500+

Shirley Ryan AbilityLab

Collaborator

Trials
212
Recruited
17,900+

Published Research Related to This Trial

The OP-ENS study demonstrated that peer navigators, who are trained individuals with disabilities, effectively improved health access for Medicaid beneficiaries by building trust and addressing social health concerns like poverty and discrimination.
The community-based participatory approach allowed peer navigators to refine the intervention based on their experiences, leading to a focus on social determinants of health and enhanced support for peers with mental health needs, highlighting the importance of consumer input in healthcare interventions.
Relationships at Work: Integrating the Perspectives of Disability Partners to Enhance a Peer Navigation Intervention.Herrman, D., Papadimitriou, C., Green, B., et al.[2022]
The study found that 4.2% of community-dwelling adults reported harmful adverse events in healthcare, primarily due to medication errors (45.5%) and misdiagnosis (25.6%), indicating a need for improved safety measures.
Self-reported harmful events were more common among individuals who had been hospitalized recently and those with lower incomes, suggesting that targeted interventions may be necessary for these vulnerable groups.
Self-reported adverse events in health care that cause harm: a population-based survey.Adams, RJ., Tucker, G., Price, K., et al.[2020]
A symposium with 31 healthcare professionals highlighted that preventing adverse events in community care requires a multi-faceted approach involving policy changes at various levels, including system integration and improved communication among providers.
Key recommendations from the symposium include prioritizing education for clinicians and caregivers, enhancing organizational culture, and leveraging technology to improve patient safety and reduce adverse events.
Adverse events in community care: implications for practice, policy and research.Masotti, P., Green, M., McColl, MA.[2019]

Citations

Relationships at Work: Integrating the Perspectives of Disability Partners to Enhance a Peer Navigation Intervention. [2022]
Our Peers-Empowerment and Navigational Support (OP-ENS): Development of a Peer Health Navigator Intervention to Support Medicaid Beneficiaries With Physical Disabilities. [2021]
Consumer evaluation of a disability care coordination organization. [2019]
Effectiveness of peer-delivered Center for Independent Living supports for individuals with psychiatric disabilities: A randomized, controlled trial. [2022]
Developing and Evaluating a Quality Improvement Intervention to Facilitate Patient Navigation in the Accountable Health Communities Model. [2021]
Self-reported adverse events in health care that cause harm: a population-based survey. [2020]
Adverse events in community care: developing a research agenda. [2022]
Adverse events in community care: implications for practice, policy and research. [2019]
[Adverse drug effects in the community pharmacy]. [2015]
10.United Statespubmed.ncbi.nlm.nih.gov
Identifying Adverse Drug Events in Older Community-Dwelling Patients. [2020]
11.United Statespubmed.ncbi.nlm.nih.gov
Partners in policymaking: the first five years. [2014]
12.United Statespubmed.ncbi.nlm.nih.gov
Peer Support Interventions in Physical Medicine and Rehabilitation: A Framework to Advance the Field. [2022]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security